(19)
(11) EP 4 798 303 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24804643.5

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
A61P 17/00(2006.01)
C07K 16/28(2006.01)
A61P 37/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2875; C07K 2317/33; C07K 2317/732; C07K 2317/734; C07K 2317/76; C07K 2317/92; A61P 17/00; A61P 37/02
(86) International application number:
PCT/US2024/052505
(87) International publication number:
WO 2025/090570 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363592351 P
03.05.2024 US 202463642002 P

(71) Applicant: AbCellera Biologics Inc.
Vancouver BC V5Y 1G6 (CA)

(72) Inventors:
  • GOODMAN, Allison
    Vancouver, British Columbia V5Y 0A1 (CA)
  • WILLIAMSON, Christopher
    Vancouver, British Columbia V5Y 0A1 (CA)
  • MACDONALD, Madeline
    Vancouver, British Columbia V5Y 0A1 (CA)
  • KUANG, Tallie
    Vancouver, British Columbia V5Y 0A1 (CA)
  • YAMNIUK, Aaron Paul
    Vancouver, British Columbia V5Y 0A1 (CA)
  • LAMEIGNERE, Emilie
    Vancouver, British Columbia V5Y 0A1 (CA)
  • DUNCAN, Sherie
    Vancouver, British Columbia V5Y 0A1 (CA)
  • BARNHART, Bryan Crawford
    Vancouver, British Columbia V5Y 0A1 (CA)
  • AMASH, Alaa
    Vancouver, British Columbia V5Y 0A1 (CA)
  • NIEMIETZ, Iwona
    Vancouver, British Columbia V5Y 0A1 (CA)

(74) Representative: EIP 
Fairfax House 15 Fulwood Place
London WC1V 6HU
London WC1V 6HU (GB)

   


(54) ANTI-OX40L ANTIBODIES AND METHODS OF USE